NDC 13985-805-50 - CMPK
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 13985-805
- Requested NDC
- 13985-805-50
- Package NDCs from labels
- 13985-805-50
- Manufacturer
- MWI (VetOne)
- Effective date
- 2026-03-20
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| CMPK - MWI (VetOne) | MWI (VetOne) | 2026-03-20 | PRESCRIPTION ANIMAL DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 13985-805-50 | CMPK | 500 mL in 1 BOTTLE, PLASTIC | INJECTION, SOLUTION | 500 | 4 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| Calcium Gluconate Monohydrate | ACTIVE INGREDIENT | CZN0MI5R31 | CMPK INJECTION, SOLUTION [MWI (VETONE)] | 2 | |
| Dextrose Monohydrate | ACTIVE INGREDIENT | LX22YL083G | CMPK INJECTION, SOLUTION [MWI (VETONE)] | 2 | |
| Magnesium Gluconate | ACTIVE INGREDIENT | T42NAD2KHC | CMPK INJECTION, SOLUTION [MWI (VETONE)] | 2 | |
| Potassium Chloride | ACTIVE INGREDIENT | 660YQ98I10 | CMPK INJECTION, SOLUTION [MWI (VETONE)] | 2 | |
| Sodium Hypophosphite Monohydrate | ACTIVE INGREDIENT | 4VN69WUP7N | CMPK INJECTION, SOLUTION [MWI (VETONE)] | 2 | |
| Calcium Cation | ACTIVE MOIETY | 2M83C4R6ZB | CMPK INJECTION, SOLUTION [MWI (VETONE)] | 2 | |
| Dextrose | ACTIVE MOIETY | IY9XDZ35W2 | CMPK INJECTION, SOLUTION [MWI (VETONE)] | 2 | |
| Magnesium cation | ACTIVE MOIETY | T6V3LHY838 | CMPK INJECTION, SOLUTION [MWI (VETONE)] | 2 | |
| Phosphorus | ACTIVE MOIETY | 27YLU75U4W | CMPK INJECTION, SOLUTION [MWI (VETONE)] | 2 | |
| Potassium cation | ACTIVE MOIETY | 295O53K152 | CMPK INJECTION, SOLUTION [MWI (VETONE)] | 2 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Potassium Chloride Extended-Release | POTASSIUM CHLORIDE | REMEDYREPACK INC. | 7ec22e8e-6643-44fe-804d-ca0b0b266663 | 2026-07-31 | Warnings, Adverse reactions | 660YQ98I10 |
| Bioplasma | SILICON DIOXIDE,POTASSIUM CHLORIDE,SODIUM SULFATE,FERROSOFERRIC PHOSPHATE,MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE,SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE,TRIBASIC CALCIUM PHOSPHATE,POTASSIUM PHOSPHATE, DIBASIC,POTASSIUM SULFATE,SODIUM CHLORIDE,CALCIUM SULFATE ANHYDROUS,CALCIUM FLUORIDE | Hyland's Inc. | dd0a7ed2-d112-4b96-e053-2995a90ac6b6 | 2026-07-30 | Warnings | 660YQ98I10 |
| Delflex | DEXTROSE MONOHYDRATE, SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE | Fresenius Medical Care de Mexico, S.A. de C.V. | a98facd6-9daa-4d37-8209-63a0599dbfaa | 2026-07-27 | Warnings, Adverse reactions | LX22YL083G |
| Potassium Chloride Extended-Release | POTASSIUM CHLORIDE | Upsher-Smith Laboratories, LLC | 02707146-331f-4511-a187-0152fc8bca85 | 2026-07-24 | Warnings, Adverse reactions | 660YQ98I10 |
| PEG 3350 and Electrolytes | POLYETHYLENE GLYCOL 3350, SODIUM SULFATE ANHYDROUS, SODIUM BICARBONATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE | A-S Medication Solutions | 19daf830-7270-4661-81b1-ded38f867f28 | 2026-07-24 | Warnings, Adverse reactions | 660YQ98I10 |
| Potassium Chloride | POTASSIUM CHLORIDE | Major Pharmaceuticals | 6c080e51-4eb7-4e96-b29f-eb1cce381304 | 2026-07-14 | Warnings, Adverse reactions | 660YQ98I10 |
| Dextrose | DEXTROSE MONOHYDRATE | Hospira, Inc. | 4ed365da-4e62-4329-c1b9-c197ab4fb6e1 | 2026-07-13 | Warnings, Adverse reactions | LX22YL083G |
| Infant Dextrose | DEXTROSE | Henry Schein, Inc. | ce71d929-d11e-444c-bd45-e025d5172057 | 2026-07-13 | Warnings, Adverse reactions | LX22YL083G |
| Potassium Chloride | POTASSIUM CHLORIDE | ATLANTIC BIOLOGICALS CORP. | 104ccc91-2aaf-4bb7-bb64-77c29413f60e | 2026-07-10 | Warnings, Adverse reactions | 660YQ98I10 |
| The Cell Salt Co. Daily Blend 12 in 1 | CALC FLUOR, CALC PHOS, CALC SULPH, FERRUM PHOS, KALI MUR, KALI PHOS, KALI SULPH, MAG PHOS, NAT MUR, NAT PHOS, NAT SULPH, SILICEA | The Cell Salt Company LLC | 55826f59-acf4-7370-e063-6394a90afed7 | 2026-07-01 | Warnings | 660YQ98I10 |
| POTASSIUM CHLORIDE | POTASSIUM CHLORIDE | Hospira, Inc. | 559a0a8c-a8fe-40a5-b196-21f9308780ab | 2026-07-01 | Warnings, Adverse reactions | 660YQ98I10 |
| Potassium Chloride | POTASSIUM CHLORIDE | A-S Medication Solutions | 30527e49-6648-44f3-97b2-9c51783ac003 | 2026-07-01 | Warnings, Adverse reactions | 660YQ98I10 |
| Potassium Chloride | POTASSIUM CHLORIDE | Amneal Pharmaceuticals NY LLC | 590dd25c-c4cb-489a-a09b-eccbf1d37c1f | 2026-07-01 | Warnings, Adverse reactions | 660YQ98I10 |
| Leukotrap WB System | CPDA-1 BLOOD BAG COLLECTION SYSTEM | GVS TM INC | 54fd8a72-0527-df0c-e063-6294a90abe75 | 2026-06-24 | LX22YL083G | |
| Leukotrap WB System | CPDA-1 BLOOD BAG COLLECTION SYSTEM | GVS TM INC | 54fddca1-b40c-7af0-e063-6294a90a410e | 2026-06-24 | LX22YL083G | |
| Leukotrap WB System | CPDA-1 BLOOD BAG COLLECTION SYSTEM | GVS TM INC | 54fdf83e-f641-1f69-e063-6394a90ab750 | 2026-06-24 | LX22YL083G | |
| Dextrose | DEXTROSE MONOHYDRATE | Hospira, Inc. | 672264e3-9709-4bba-2a9d-12bf70c7396a | 2026-06-24 | Warnings, Adverse reactions | LX22YL083G |
| calcium gluconate | CALCIUM GLUCONATE | Amneal Pharmaceuticals Private Limited | 787603c6-3f50-473a-8e3b-71dcf6d86964 | 2026-06-23 | Warnings, Adverse reactions | CZN0MI5R31 |
| Potassium Chloride | POTASSIUM CHLORIDE | St. Mary's Medical Park Pharmacy | 549c9d28-bf8b-2dc2-e063-6294a90abe7b | 2026-06-19 | Warnings, Adverse reactions | 660YQ98I10 |
| ACD A | CITRIC ACID MONOHYDRATE, DEXTROSE MONOHYDRATE, AND TRISODIUM CITRATE DIHYDRATE | Terumo BCT, Ltd. | 395aec48-198a-4aed-8e38-7accfb3232f9 | 2026-06-15 | Warnings, Adverse reactions | LX22YL083G |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.